-

Thermo Fisher Scientific Increases Accessibility to Research With the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference

WALTHAM, Mass.--(BUSINESS WIRE)--As the world leader in serving science, Thermo Fisher Scientific is proud to announce the launch of two new electron microscopes that will be unveiled at Microscopy & Microanalysis (M&M) in Salt Lake City, Utah, July 27-31, each significantly contributing to the democratization of research in the sciences.

Scios 3 FIB-SEM offers high-powered versatility
The Thermo Scientific™ Scios™ 3 is a focused ion beam (FIB) scanning electron microscope (SEM) with automation to dramatically improve site-specific quality control. The Scios 3 FIB-SEM offers increased productivity for both industry and academia with enhanced lamella preparation, due to advances in FIB column performance. Ease-of-use upgrades will benefit microscopists of all experience levels.

“Researchers across the globe seek new and better materials for various applications – from clean energy and aerospace to productivity of digital devices,” said David Wall, vice president and general manager of materials science for Thermo Fisher. “The current pace of the development of new materials and their increasing complexity poses significant challenges, and Scios 3 addresses those challenges head-on with world-class advancements designed to serve both academia and industry.”

With advanced automation and high-throughput, Scios 3 improves ease of use, reliability and productivity. To learn more, stop by booth #1734 at M&M for a live demonstration or visit thermofisher.com/scios3.

Talos 12 adapts to researchers across disciplines and experience levels
Thermo Fisher has evolved the popular Talos transmission electron microscope (TEM) design, culminating in the Thermo Scientific Talos™ 12 TEM, making leading-edge sample analysis more accessible than ever for biological research, pathology and drug development.

“We’re pleased to introduce Talos 12 at M&M this year to bring transmission electron microscopy to more researchers,” said Trisha Rice, vice president and general manager of life sciences at Thermo Fisher. “A wide array of laboratories can now benefit from this adaptable 120kV instrument. Not only does the reduced footprint and next-generation enclosure fit into more lab spaces, but the streamlined workflows – from routine imaging of cells and tissues to AI-assisted sample characterization to cryo-EM – enable the user-friendly Talos 12 to support remote operation for collaboration regardless of location.”

TEM systems often require highly skilled specialists, but Talos 12 lowers those requirements with new enhancements to improve ease of use while maintaining high quality imaging with high reproducibility. To learn more, stop by booth #1734 at M&M for a live demonstration or visit thermofisher.com/talos12.

Stop by booth #1734 to see Scios, Talos and more
Thermo Fisher will have a significant presence at the Salt Palace Convention Center. In addition to live demonstrations of Scios 3 and Talos 12, several other industry-leading solutions will be on full display.

Stop by booth #1734 to engage with Thermo Fisher subject-matter experts as they discuss the latest advancements in microscopy innovation and analytical research technology.

Additionally, Thermo Fisher has hosted a “Women in Microscopy” breakfast at M&M for more than two decades and will continue that tradition at the Hyatt Regency on the morning of July 30. Dr. Amelia Dempere, Director of the Nanoscale Research Facility (NRF) at the University of Florida, will talk about her career journey and the ever-increasing importance of women in research.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media:
Alex Runner
Thermo Fisher Scientific
alex.runner@thermofisher.com

Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media:
Alex Runner
Thermo Fisher Scientific
alex.runner@thermofisher.com

Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

More News From Thermo Fisher

Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of Life-changing Therapies

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its flagship U.S. Bioprocess Design Center (BDC) at the company’s Plainville, Mass., site, expanding the facility to support customers in developing and scaling biologics. The new center brings together advanced bioproduction capabilities and hands-on collaboration to help customers accelerate process development and bring transformative therapies to patients faste...

Thermo Fisher Scientific to Host Investor Day

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will hold its 2026 Investor Day on Wednesday, May 20, 2026, starting at 9:00 a.m. ET in New York City. The format will feature presentations by members of Thermo Fisher Scientific’s senior management team and conclude with a Q&A session. The live webcast of the presentation can be accessed via the Investors section of our website, https://ir.thermofisher.com. A replay of the webc...

Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food...
Back to Newsroom